National Planning Corporation’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,900
| Closed | -$167K | – | 128 |
|
|
2017
Q3 | $167K | Sell |
3,900
-203
| -5% | -$8.69K | 0.01% | 645 |
|
|
2017
Q2 | $158K | Sell |
4,103
-226
| -5% | -$8.7K | 0.01% | 704 |
|
|
2017
Q1 | $218K | Buy |
4,329
+667
| +18% | +$33.6K | 0.02% | 613 |
|
|
2016
Q4 | $185K | Sell |
3,662
-21
| -0.6% | -$1.06K | 0.01% | 637 |
|
|
2016
Q3 | $182K | Hold |
3,683
| – | – | 0.01% | 597 |
|
|
2016
Q2 | $251K | Buy |
3,683
+110
| +3% | +$7.5K | 0.02% | 540 |
|
|
2016
Q1 | $187K | Hold |
3,573
| – | – | 0.02% | 584 |
|
|
2015
Q4 | $389K | Sell |
3,573
-917
| -20% | -$99.8K | 0.03% | 473 |
|
|
2015
Q3 | $880K | Sell |
4,490
-13
| -0.3% | -$2.55K | 0.08% | 233 |
|
|
2015
Q2 | $1.15M | Buy |
4,503
+3
| +0.1% | +$763 | 0.1% | 199 |
|
|
2015
Q1 | $1.64M | Buy |
4,500
+200
| +5% | +$72.9K | 0.15% | 140 |
|
|
2014
Q4 | $1.22M | Buy |
4,300
+300
| +8% | +$84.8K | 0.09% | 211 |
|
|
2014
Q3 | $827K | Buy |
+4,000
| New | +$827K | 0.06% | 287 |
|
|
2013
Q4 | – | Sell |
-2,043
| Closed | -$1.16M | – | 708 |
|
|
2013
Q3 | $1.16M | Buy |
+2,043
| New | +$1.16M | 0.11% | 196 |
|